Literature DB >> 2958433

Radioimmunoassay for atrial natriuretic factor.

J Gutkowska1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2958433     DOI： 10.1016/0883-2897(87)90009-2

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN： 0883-2897


× No keyword cloud information.
  7 in total

1.  Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.

Authors:  J Gutkowska; M Jankowski; C Lambert; S Mukaddam-Daher; H H Zingg; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats.

Authors:  J Gutkowska; M Jankowski; S Mukaddam-Daher; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Renal effects of TAPP, a highly selective mu-opioid agonist.

Authors:  J Gutkowska; P W Schiller
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome.

Authors:  M Huang; P Jolicoeur
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Estrogen receptors activate atrial natriuretic peptide in the rat heart.

Authors:  M Jankowski; G Rachelska; W Donghao; S M McCann; J Gutkowska
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

6.  Altered regulation of natriuretic peptides in the rat heart by prenatal exposure to morphine.

Authors:  S Ernest; M Jankowski; S Mukaddam-Daher; J Cusson; J Gutkowska
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

7.  Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.

Authors:  Rouwayda El-Ayoubi; Ahmed Menaouar; Jolanta Gutkowska; Suhayla Mukaddam-Daher
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.